NDC 51672-2102-01 - Childrens Cetirizine Hydrochloride Sugar Free Grape
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2102
- Requested NDC
- 51672-2102-01
- Package NDCs from labels
- 51672-2102-4, 51672-2102-8, 51672-2102-1, 51672-2102-2, 51672-2102-7, 51672-2102-01
- Manufacturer
- VERITYRX, LLC
- Effective date
- 2025-11-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Childrens Cetirizine Hydrochloride Sugar Free Grape - VERITYRX, LLC | VERITYRX, LLC | 2025-11-02 | HUMAN OTC DRUG LABEL |
| Children's Cetirizine Hydrochloride Oral Solution Sugar Free Grape | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | Sun Pharma Canada Inc. | 2025-07-02 | HUMAN OTC DRUG LABEL |
| Childrens Cetirizine Hydrochloride Sugar Free Grape - A-S Medication Solutions | A-S Medication Solutions | 2024-01-23 | HUMAN OTC DRUG LABEL |
| Childrens Cetirizine Hydrochloride Sugar Free Grape - Proficient Rx LP | Proficient Rx LP | 2022-10-01 | HUMAN OTC DRUG LABEL |
| Children's Cetirizine Hydrochloride Oral Solution Sugar Free Grape | Preferred Pharmaceuticals Inc. | 2020-04-16 | HUMAN OTC DRUG LABEL |
| Children's Cetirizine Hydrochloride Oral Solution Sugar Free Grape | NuCare Pharmaceuticals,Inc. | 2018-05-15 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2102-1 | Childrens Cetirizine Hydrochloride Sugar Free Grape | 1 in 1 CARTON | SOLUTION | 1 | 6 | |
| 51672-2102-1 | Childrens Cetirizine Hydrochloride Sugar Free Grape | 240 mL in 1 BOTTLE | SOLUTION | 240 | 6 | |
| 51672-2102-2 | Childrens Cetirizine Hydrochloride Sugar Free Grape | 2 in 1 CARTON | SOLUTION | 2 | 6 | |
| 51672-2102-2 | Childrens Cetirizine Hydrochloride Sugar Free Grape | 120 mL in 1 BOTTLE | SOLUTION | 120 | 6 | |
| 51672-2102-4 | Childrens Cetirizine Hydrochloride Sugar Free Grape | 1 in 1 CARTON | SOLUTION | 1 | 6 | |
| 51672-2102-4 | Childrens Cetirizine Hydrochloride Sugar Free Grape | 60 mL in 1 BOTTLE | SOLUTION | 60 | 6 | |
| 51672-2102-7 | Childrens Cetirizine Hydrochloride Sugar Free Grape | 240 mL in 1 BOTTLE | SOLUTION | 240 | 6 | |
| 51672-2102-7 | Childrens Cetirizine Hydrochloride Sugar Free Grape | 2 in 1 CARTON | SOLUTION | 2 | 6 | |
| 51672-2102-8 | Childrens Cetirizine Hydrochloride Sugar Free Grape | 1 in 1 CARTON | SOLUTION | 1 | 6 | |
| 51672-2102-8 | Childrens Cetirizine Hydrochloride Sugar Free Grape | 120 mL in 1 BOTTLE | SOLUTION | 120 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2102 | CHILDRENS CETIRIZINE HYDROCHLORIDE SUGAR FREE GRAPE (CETIRIZINE HYDROCHLORIDE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 10 package rows | 20210422_54d72d7a-1f5b-4b36-bf76-ab7aef6243ab.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2102-8 | ML - Milliliter | 51672-2102 | 9c5ff033-2296-40e3-82ef-17b9cdcc2a1e | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | ICU Medical Inc. | 189b8ac6-e346-454f-b501-7645590ca4f8 | 2025-10-29 | Warnings, Adverse reactions | NVG71ZZ7P0 |
| SKIN TAG REMOVER | SALICYLIC ACID | Shenzhen Yaozhihong Technology Co., Ltd. | 4246d4d5-9955-ba5a-e063-6394a90a8448 | 2025-10-29 | Warnings | Q40Q9N063P |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2025-10-29 | Warnings | PDC6A3C0OX |
| hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Publix Super Markets Inc | 354a640c-bc7e-45c8-9df0-8b5b01767f5c | 2025-10-29 | Warnings | PDC6A3C0OX |
| Sterile Water | WATER | ICU Medical Inc. | 1c0bbcb7-5ed6-4ee7-b297-080d3359474e | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Cetirizine | CETIRIZINE HYDROCHLORIDE | A-S Medication Solutions | 88c3d23e-a0d8-4464-9414-666d74f11f66 | 2025-10-28 | Warnings | 64O047KTOA |
| Cetirizine Hydrochloride | CETIRIZINE HYDROCHLORIDE TABLETS | Bryant Ranch Prepack | e4324124-13f8-4450-9fd6-686bd6e25578 | 2025-10-28 | Warnings | 64O047KTOA |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2025-10-27 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| LACRIFRESH HYDRAPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41bbd23e-0ec8-eb18-e063-6294a90a46d1 | 2025-10-27 | Warnings | PDC6A3C0OX |
| LACRIFRESH HYDRAMAXPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41be1604-89b4-7ec3-e063-6294a90a3331 | 2025-10-27 | Warnings | PDC6A3C0OX |
| Cetirizine Hydrochloride | CETIRIZINE HYDROCHLORIDE | Bionpharma Inc. | 41d7af88-87b4-370e-e063-6294a90a8af6 | 2025-10-24 | Adverse reactions | 1014673 64O047KTOA |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97aa5b-62e2-0664-e053-2a91aa0ac341 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | H E B | 3d03ce42-e671-6d76-e054-00144ff8d46c | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 022dd494-cb3c-4fa7-be99-4c38fabdc612 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97c4d2-e41d-5bb6-e053-2a91aa0a3163 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | CVS Pharmacy | 94e4a6f3-43d0-b2a5-e053-2a95a90aa115 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 5e83d3ef-91c5-1c3a-e053-2a91aa0a93ed | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f3bc-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f37a-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | a381838b-d1ae-11c5-e053-2a95a90a7bcb | 2025-10-24 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.